Targacept and Catalyst Biosciences annunce merger agreement
Targacept and Catalyst Biosciences announced an agreement to merge the two companies into a combined entity named Catalyst Biosciences. Catalyst will initially own 65 percent of the combined company, and the operations of both companies that will be combined. March 05, 2015